Eastwood Bio Medical Canada Stock Beta
| EBM Stock | CAD 0.75 0.05 6.25% |
Eastwood Bio Medical Canada fundamentals help investors to digest information that contributes to Eastwood Bio's financial success or failures. It also enables traders to predict the movement of Eastwood Stock. The fundamental analysis module provides a way to measure Eastwood Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastwood Bio stock.
Eastwood | Beta |
Eastwood Bio Medical Canada Company Beta Analysis
Eastwood Bio's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Eastwood Bio Beta | 0.28 |
Most of Eastwood Bio's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastwood Bio Medical Canada is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Eastwood Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Eastwood Bio is extremely important. It helps to project a fair market value of Eastwood Stock properly, considering its historical fundamentals such as Beta. Since Eastwood Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Eastwood Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Eastwood Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Eastwood Bio Medical Canada has a Beta of 0.277. This is 67.79% lower than that of the Consumer Staples Distribution & Retail sector and 80.07% lower than that of the Consumer Staples industry. The beta for all Canada stocks is notably lower than that of the firm.
Eastwood Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastwood Bio's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastwood Bio could also be used in its relative valuation, which is a method of valuing Eastwood Bio by comparing valuation metrics of similar companies.Eastwood Bio is currently under evaluation in beta category among its peers.
Eastwood Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Eastwood Bio from analyzing Eastwood Bio's financial statements. These drivers represent accounts that assess Eastwood Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Eastwood Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 78.2M | 84.1M | 82.7M | 114.7M | 103.2M | 79.5M | |
| Enterprise Value | 78.1M | 84.1M | 82.7M | 114.7M | 103.2M | 78.8M |
As returns on the market increase, Eastwood Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eastwood Bio is expected to be smaller as well.
Eastwood Fundamentals
| Return On Equity | -7.47 | ||||
| Return On Asset | -0.64 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 51.72 M | ||||
| Shares Outstanding | 68.89 M | ||||
| Shares Owned By Insiders | 69.55 % | ||||
| Number Of Shares Shorted | 63 | ||||
| Price To Earning | (11.43) X | ||||
| Price To Book | 2,943 X | ||||
| Price To Sales | 79.05 X | ||||
| Revenue | 867.94 K | ||||
| Gross Profit | 902.74 K | ||||
| EBITDA | (398.19 K) | ||||
| Net Income | (546.6 K) | ||||
| Cash And Equivalents | 708.26 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 23.08 K | ||||
| Current Ratio | 3.42 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (16.89 K) | ||||
| Short Ratio | 0.05 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 51.66 M | ||||
| Total Asset | 489.14 K | ||||
| Retained Earnings | (5.54 M) | ||||
| Working Capital | (1.18 M) | ||||
| Net Asset | 489.14 K |
About Eastwood Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastwood Bio Medical Canada's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastwood Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastwood Bio Medical Canada based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.